|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2005-6-10
|
|
pubmed:abstractText |
Rabeprazole in combination with amoxicillin and metronidazole (RAM) has been shown to be an effective second-line treatment of Helicobacter pylori infection. The effects were compared of 7-day low-dose and high dose rabeprazole in RAM for the primary treatment of H. pylori infection in Chinese patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0815-9319
|
|
pubmed:author |
pubmed-author:ChanAnnie O OAO,
pubmed-author:ChanChi KuenCK,
pubmed-author:CheungKess LKL,
pubmed-author:FungFiona M YFM,
pubmed-author:HoVicky Y KVY,
pubmed-author:HuangJiaqingJ,
pubmed-author:HuiChee-KinCK,
pubmed-author:LaiKam ChuenKC,
pubmed-author:LamShiu KumSK,
pubmed-author:TongTeresa S MTS,
pubmed-author:WongBenjamin C YBC,
pubmed-author:WongWai ManWM,
pubmed-author:XiaHarry H XHH
|
|
pubmed:copyrightInfo |
(c) 2005 Blackwell Publishing Asia Pty Ltd.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
935-40
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15946144-2-Pyridinylmethylsulfinylbenzimidazoles,
pubmed-meshheading:15946144-Adolescent,
pubmed-meshheading:15946144-Adult,
pubmed-meshheading:15946144-Aged,
pubmed-meshheading:15946144-Aged, 80 and over,
pubmed-meshheading:15946144-Amoxicillin,
pubmed-meshheading:15946144-Anti-Bacterial Agents,
pubmed-meshheading:15946144-Benzimidazoles,
pubmed-meshheading:15946144-Biopsy,
pubmed-meshheading:15946144-Dose-Response Relationship, Drug,
pubmed-meshheading:15946144-Drug Therapy, Combination,
pubmed-meshheading:15946144-Dyspepsia,
pubmed-meshheading:15946144-Endoscopy, Gastrointestinal,
pubmed-meshheading:15946144-Enzyme Inhibitors,
pubmed-meshheading:15946144-Female,
pubmed-meshheading:15946144-Helicobacter Infections,
pubmed-meshheading:15946144-Helicobacter pylori,
pubmed-meshheading:15946144-Humans,
pubmed-meshheading:15946144-Male,
pubmed-meshheading:15946144-Metronidazole,
pubmed-meshheading:15946144-Middle Aged,
pubmed-meshheading:15946144-Omeprazole,
pubmed-meshheading:15946144-Prevalence,
pubmed-meshheading:15946144-Proton-Translocating ATPases,
pubmed-meshheading:15946144-Pyloric Antrum,
pubmed-meshheading:15946144-Retrospective Studies,
pubmed-meshheading:15946144-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients.
|
|
pubmed:affiliation |
Department of Medicine, Queen Mary Hospital, University of Hong Kong, Pokfulam Road, Hong Kong.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
